Skip to main content
Erschienen in: Urolithiasis 2/2014

01.04.2014 | Original Paper

Comparison one-step procedure with two-step procedure in percutaneous nephrolithotomy

verfasst von: Szu-Han Chen, Wen-Jeng Wu, Yii-Her Chou, Hsin-Chih Yeh, Chia-Chun Tsai, Kuang-Shun Chueh, Nien-Ting Hou, Siou-Jin Chiu, Hung-Pin Tu, Ching-Chia Li

Erschienen in: Urolithiasis | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to compare the effects of one-step percutaneous nephrolithotomy (PCNL) by the urologist alone and two-step PCNL by cooperating with the radiologist. We included 168 patients who underwent surgery by the same surgeon, 83 who underwent two-step PCNL, in which percutaneous nephrostomy insertion was performed by the radiologists on the day before endo-surgery, and 85 who underwent one-step PCNL, which involved the creation of a nephrostomy tract and performing the PCNL at the same time in the operating room, by a urologist. We compared the perioperative and postoperative parameters between these two groups. The result revealed that there were no significant differences between one-step and two-step PCNL in the decreases in haemoglobin level and blood transfusion volume, and the hospital stay was shorter in the one-step PCNL group. In addition, the one-step PCNL group was associated with significantly lower visual analogue score (VAS), which were 2.3, 1.1, and 0.4 on the post-operative days 1, 2, and 3, respectively, compared with 3.2, 1.7, and 1.0 in the two-step PCNL group. The number of parenteral analgesic prescriptions was fewer in the one-step PCNL group (0.8 ± 1.1 amps/vials) than in the two-step PCNL group (4.1 ± 2.4 amps/vials). Furthermore, different stone locations barely affected VAS and analgesic administrations. The results indicate that the one-step PCNL by the urologist alone, compared to two-step PCNL with the radiologist, has better wound pain outcome and shorter hospital stay with comparable successful rate and complication grade
Literatur
1.
Zurück zum Zitat Ritter M, Krombach P, Michel MS (2011) Percutaneous stone removal. Eur Urol 10(5):433–439CrossRef Ritter M, Krombach P, Michel MS (2011) Percutaneous stone removal. Eur Urol 10(5):433–439CrossRef
2.
Zurück zum Zitat Mishra S, Sabnis RB, Kurien A et al (2010) Questioning the wisdom of tubeless percutaneous nephrolithotomy (PCNL): a prospective randomized controlled study of early tube removal vs tubeless PCNL. BJU Int 106(7):1045–1049PubMedCrossRef Mishra S, Sabnis RB, Kurien A et al (2010) Questioning the wisdom of tubeless percutaneous nephrolithotomy (PCNL): a prospective randomized controlled study of early tube removal vs tubeless PCNL. BJU Int 106(7):1045–1049PubMedCrossRef
3.
Zurück zum Zitat Frattini A, Barbieri A, Salsi P et al (2001) One shot: a novel method to dilate the nephrostomy access for percutaneous lithotripsy. J Endourol 15(9):919–923PubMedCrossRef Frattini A, Barbieri A, Salsi P et al (2001) One shot: a novel method to dilate the nephrostomy access for percutaneous lithotripsy. J Endourol 15(9):919–923PubMedCrossRef
4.
Zurück zum Zitat de la Rosette JJ, Opondo D, Daels FP et al (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62(2):246–255PubMedCrossRef de la Rosette JJ, Opondo D, Daels FP et al (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62(2):246–255PubMedCrossRef
5.
Zurück zum Zitat Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205PubMedCentralPubMedCrossRef Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Aminsharifi A, Alavi M, Sadeghi G et al (2011) Renal parenchymal damage after percutaneous nephrolithotomy with one-stage tract dilation technique: a randomized clinical trial. J Endourol 25(6):927–931PubMedCrossRef Aminsharifi A, Alavi M, Sadeghi G et al (2011) Renal parenchymal damage after percutaneous nephrolithotomy with one-stage tract dilation technique: a randomized clinical trial. J Endourol 25(6):927–931PubMedCrossRef
7.
Zurück zum Zitat de la Rosette JJ, Tsakiris P, Ferrandino MN et al (2008) Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. European Urol 54(6):1262–1269CrossRef de la Rosette JJ, Tsakiris P, Ferrandino MN et al (2008) Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. European Urol 54(6):1262–1269CrossRef
8.
Zurück zum Zitat Liu L, Zheng S, Xu Y et al (2010) Systematic review and meta-analysis of percutaneous nephrolithotomy for patients in the supine versus prone position. J Endourol 24(12):1941–1946PubMedCrossRef Liu L, Zheng S, Xu Y et al (2010) Systematic review and meta-analysis of percutaneous nephrolithotomy for patients in the supine versus prone position. J Endourol 24(12):1941–1946PubMedCrossRef
9.
Zurück zum Zitat Hollenbeck BK, Schuster TG, Faerber GJ et al (2001) Flexible ureteroscopy in conjunction with in situ lithotripsy for lower pole calculi. Urology 58(6):859–862PubMedCrossRef Hollenbeck BK, Schuster TG, Faerber GJ et al (2001) Flexible ureteroscopy in conjunction with in situ lithotripsy for lower pole calculi. Urology 58(6):859–862PubMedCrossRef
10.
Zurück zum Zitat Lam HS, Lingeman JE, Barron M et al (1992) Staghorn calculi: analysis of treatment results between initial percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy monotherapy with reference to surface area. J Urol 147(5):1219–1225PubMed Lam HS, Lingeman JE, Barron M et al (1992) Staghorn calculi: analysis of treatment results between initial percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy monotherapy with reference to surface area. J Urol 147(5):1219–1225PubMed
11.
Zurück zum Zitat Auge BK, Sekula JJ, Springhart WP et al (2004) In vitro comparison of fragmentation efficiency of flexible pneumatic lithotripsy using 2 flexible ureteroscopes. J Urol 172(3):967–970PubMedCrossRef Auge BK, Sekula JJ, Springhart WP et al (2004) In vitro comparison of fragmentation efficiency of flexible pneumatic lithotripsy using 2 flexible ureteroscopes. J Urol 172(3):967–970PubMedCrossRef
12.
Zurück zum Zitat Xue W, Pacik D, Boellaard W et al (2012) Management of single large nonstaghorn renal stones in the CROES PCNL Global Study. J Urol 187(4):1293–1297PubMedCrossRef Xue W, Pacik D, Boellaard W et al (2012) Management of single large nonstaghorn renal stones in the CROES PCNL Global Study. J Urol 187(4):1293–1297PubMedCrossRef
13.
Zurück zum Zitat Ni S, Qiyin C, Tao W et al (2011) Tubeless percutaneous nephrolithotomy is associated with less pain and shorter hospitalization compared with standard or small bore drainage: a meta-analysis of randomized, controlled trials. Urology 77(6):1293–1298PubMedCrossRef Ni S, Qiyin C, Tao W et al (2011) Tubeless percutaneous nephrolithotomy is associated with less pain and shorter hospitalization compared with standard or small bore drainage: a meta-analysis of randomized, controlled trials. Urology 77(6):1293–1298PubMedCrossRef
Metadaten
Titel
Comparison one-step procedure with two-step procedure in percutaneous nephrolithotomy
verfasst von
Szu-Han Chen
Wen-Jeng Wu
Yii-Her Chou
Hsin-Chih Yeh
Chia-Chun Tsai
Kuang-Shun Chueh
Nien-Ting Hou
Siou-Jin Chiu
Hung-Pin Tu
Ching-Chia Li
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 2/2014
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-013-0616-1

Weitere Artikel der Ausgabe 2/2014

Urolithiasis 2/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.